The effect of SGLT2 inhibitor on clinical outcomes in patients with type 2 diabetes and atrial fibrillation

被引：0
|
作者：
Shin, S. H. [1 ]
Cho, Y. [1 ]
Park, M. A. [2 ]
Jang, J. H. [1 ]
Kim, D. Y. [1 ]
Kim, S. H. [1 ]
机构：
[1] Inha Univ Hosp, Incheon, South Korea
[2] Hanmi, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation
    Cho, Yongin
    Shin, Sung-Hee
    Park, Min-Ae
    Suh, Young Ju
    Park, Sojeong
    Jang, Ji-Hun
    Kim, Dae-Young
    Kim, So Hun
    PLOS ONE, 2025, 20 (02):
  • [2] Cardiovascular outcomes with SGLT2 inhibitors in patients with atrial fibrillation and type 2 diabetes
    Kim, S.
    Cho, Y.
    Suh, Y.
    Seo, D.
    Kim, Y.
    Shin, S-H
    DIABETOLOGIA, 2024, 67 : S342 - S342
  • [3] Cardiovascular and Mortality Outcomes with SGLT2 Inhibitors in Patients with Atrial Fibrillation and Type 2 Diabetes
    Kim, So Hun
    Cho, Yongin
    Seo, Da Hea
    Kim, Youngjoon
    Park, Minae
    Suh, Young Ju
    Shin, Sung-Hee
    DIABETES, 2024, 73
  • [4] Effect of SGLT2 on Cardiovascular Events in Type 2 Diabetic Patients with Atrial Fibrillation
    Zhang, Yuan
    Chen, Yixin
    Deng, Junhao
    Hu, Pengwei
    Tang, Zefang
    Mei, Jing
    Li, Shoachun
    DIABETES, 2020, 69
  • [5] Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study
    Nakhleh, Afif
    Othman, Areen
    Masri, Amin
    Zloczower, Moshe
    Zolotov, Sagit
    Shehadeh, Naim
    BIOMEDICINES, 2023, 11 (10)
  • [6] Should SGLT2 Inhibitors Be Part of the Standard Treatment for Atrial Fibrillation in Type 2 Diabetes?
    Antonio, Rodolfo San
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2023, 9 (02) : 263 - 264
  • [7] Influence on urination of SGLT2 inhibitor in type 2 diabetes
    Sasaki, Junko
    Shikuma, Junpei
    Ito, Rokuro
    Odawara, Masato
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S98 - S98
  • [8] SGLT2 inhibitor shows promise in type 2 diabetes
    Nature Reviews Drug Discovery, 2010, 9 (3) : 182 - 182
  • [9] DAPAGLIFLOZIN, AN SGLT2 INHIBITOR FOR THE TREATMENT OF TYPE 2 DIABETES
    Demaris, K. M.
    White, J. R.
    DRUGS OF TODAY, 2013, 49 (05) : 289 - 301
  • [10] SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
    Chan, Yi-Hsin
    Chao, Tze-Fan
    Chen, Shao-Wei
    Lee, Hsin-Fu
    Li, Pei-Ru
    Yeh, Yung-Hsin
    Kuo, Chi-Tai
    See, Lai-Chu
    Lip, Gregory Y. H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10): : 2617 - 2629
12345